3XV-38450-40409 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-24
Dose 1 — Pfizer-BioNTech
2021-04-14
Dose 2 — Pfizer-BioNTech
2021-12-07
Registered in v-safe
2021-12-07
Dose 3 — Pfizer-BioNTech
2021-12-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-16
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-12-21
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-13
Survey response — day 35, dose 3
MedDRA: Diarrhoea — Feeling: Poor · Be unable to do your normal daily activities

Free text: Diarrhea

MedDRA releases: 2024-11 · check-in free text available
2022-01-18
Survey response — day 42, dose 3
MedDRA: Headache, Respiratory tract congestion — Feeling: Fair

Free text: Headache and congestion

MedDRA releases: 2024-11 · check-in free text available
2022-03-08
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-24	Pfizer-BioNTech	No
2	2021-04-14	Pfizer-BioNTech	No
3	2021-12-07	Pfizer-BioNTech	No

Free text

Release 10 — day 35, dose 3

2022-01-13

Symptoms: Diarrhea

Release 10 — day 42, dose 3

2022-01-18

Symptoms: Headache and congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diarrhoea	·	·	✓
SD	Headache	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release